NPC1L1 and sitosterolemia: Given that NPC1L1 genetic inactivation resulted in even lower phytosterol levels raises the possibility that a more potent inhibitor of NPC1L1 mediated phytosterol transport could lower phytosterol levels further and be a more efficacious therapy to treat phytosterolemia.